Tenax Therapeutics, Inc.
TENX · NASDAQ
Bulios Fair Price
$2.29
18.0% upside
Current Price
$1.94
According to Bulios Fair Price, TENX is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Tenax Therapeutics, Inc. (TENX) is a pharmaceutical company specializing in the development and commercialization of drugs for cardiovascular diseases and other serious health conditions. With high standards of scientific research and innovative treatment methods, Tenax Therapeutics is a key player in the pharmaceutical industry. Their products have the potential to improve treatment and the quality of life for patients with cardiovascular issues. The company is known for its commitment to scientific excellence and innovations in the field of pharmacy. Tenax Therapeutics, Inc. (TENX) shares could be suitable for investors looking to invest in a sector with high potential for scientific advancement and improved healthcare.
Sector
Healthcare
Industry
Biotechnology
CEO
Christopher T. Giordano
Employees
15
Headquarters
Chapel Hill
Upcoming events
Earnings
Upcoming earnings report